Answer
Ipilimumab (Yervoy) is contraindicated in patients with hypersensitivity to ipilimumab or any excipient listed in section 6.1 of its SmPC.
Sources for this answer
- YERVOY 5 mg/ml concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.3 Contraindications · Version 47Document updated
Sources checked